In SD-OCT, the prevalence of CMO (26.67%) in our cohort was superior to that previously reported in CNGB1-related RP [13,18] but in line with the frequency of CMO in syndromic and non-syndromic RP [36]. This evidence concerns the gene CNGB1 and chronic recurrent multifocal osteomyelitis.